Frequencies for first 10,000 rows of lit_ref variable in demo2015q3 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,792 97.92 97.92 , ALJUBRAN A, ALZAHRANI A, MOHIELDIN .. | 1 0.01 97.93 , ARMENTI D AND MORITZ M. PREGNANCY O.. | 1 0.01 97.94 , ARMENTI D, MORITZ M AND COWAN S PRE.. | 1 0.01 97.95 , ARMENTI D, MORITZ M AND COWAN S. PR.. | 1 0.01 97.96 , BEN-AHARON I, GRANOT T, MEIZNER I, .. | 1 0.01 97.97 , BEN-AHARON I, GRANOT T, MEIZNER I, .. | 1 0.01 97.98 , CHEN S, YANG W, XU B, HUANG T, YANG.. | 1 0.01 97.99 , COSCIA L, SCHIRALDI M, CONSTANTINES.. | 1 0.01 98.00 , DELA ROSA M, ZHOU S, BADILLO M, ADD.. | 1 0.01 98.01 , DIECI M, FRASSOLDATI A, MAIORANA A,.. | 1 0.01 98.02 , FANGUSARO, J. POUSSAINT, T. MCLENDO.. | 1 0.01 98.03 , GOLDMAN S, SMITH L, PERKINS S, SHIR.. | 1 0.01 98.04 , GOTTENBERG J, LUPO G, BARDIN T, COM.. | 1 0.01 98.05 , GRANOT T, MEIZNER I, HASKY N, TOBAR.. | 1 0.01 98.06 , GRANOT T, MEIZNER I, HASKY N, TOBAR.. | 1 0.01 98.07 , GRANOT T, MEIZNER I, HASKY N, TOBAR.. | 2 0.02 98.09 , GRANOT T, MEIZNER I, HASKY N, TOBAR.. | 1 0.01 98.10 , GUGLER R, LAMMERT F, LAUFS U, MUSTC.. | 1 0.01 98.11 , HIRATA YUZO, YOSHIOKA SHINGORO, ET .. | 1 0.01 98.12 , HONG F, MICALLEF I, GASCOYNE R, DOG.. | 1 0.01 98.13 , KAWANO JUNKO, YAGATA HIROSHI, HAYAS.. | 1 0.01 98.14 , KOLDINGSNES W AND NOSSENT J. STAPHY.. | 1 0.01 98.15 , KOTSAKIS, A. SOULTATI, A S. AGELAKI.. | 1 0.01 98.16 , LEE J, CESARMAN E, AMBINDER R, BAIO.. | 1 0.01 98.17 , MACDONALD W, AND TURNER J. PHASE I.. | 1 0.01 98.18 , MEISSNER E, JIMMERSON L, OSINUSI A,.. | 2 0.02 98.20 , MORENO A, CORTES L F L, ORTEGA E, M.. | 1 0.01 98.21 , NEKOOVAGHT-TAK S, ULLMAN N, CARHUAP.. | 1 0.01 98.22 , OKI E, EMI Y, SAEKI H, KUSUMOTO T, .. | 1 0.01 98.23 , O^BRIEN S, LAMANNA N, KIPPS T, FLIN.. | 1 0.01 98.24 , SANADA Y, HIRATA Y, YAMADA N, WAKIY.. | 1 0.01 98.25 , SANADA Y, HIRATA Y, YAMADA N, WAKIY.. | 1 0.01 98.26 , SARKAR R, BERG T, SCHAEFER M AND SU.. | 1 0.01 98.27 , SIMA H, FIEL M, KHAITOVA V, DOUCETT.. | 1 0.01 98.28 , SUSSER S, LENZ O, CLOHERTY G, PERNE.. | 1 0.01 98.29 , TANG G, RASTOGI P, GEYER JR C, LIU .. | 1 0.01 98.30 , VIRLOGEUX V, DUFOUR C, PRADAT P, HE.. | 1 0.01 98.31 , WILDIERS H, JASSEM J, DIRIX L, GUA.. | 1 0.01 98.32 , YAMAMOTO K, SIMOYAMA A, SUZUKI M AN.. | 1 0.01 98.33 . THE EFFECT OF CINACALCET ON BONE RE.. | 1 0.01 98.34 . UTILITY OF THE LOW-ACCELERATING-DOS.. | 1 0.01 98.35 AGARWAL S, GIRISH T, HABAYEB O, DAVIE.. | 1 0.01 98.36 AKHTARI M. AZACITIDINE CAUSING PLEURO.. | 1 0.01 98.37 ALLEN KC, CHAMPLAIN AH, COTLIAR JA, B.. | 2 0.02 98.39 ANBARASAN D, HOWARD J, RYERSON LZ (20.. | 1 0.01 98.40 AROCHENA, L.. ACUTE GENERALIZED EXANT.. | 1 0.01 98.41 AYAKO A. A CASE OF CONSCIOUSNESS DIST.. | 1 0.01 98.42 BABAR SM. SIADH ASSOCIATED WITH CIPRO.. | 1 0.01 98.43 BADRELDIN W, BERNEY D, SHAMASH J, KRE.. | 1 0.01 98.44 BERNAUDIN F. MYELOABLATIVE BONE MARRO.. | 2 0.02 98.46 BLANCA SANTANA DURAN. DOSIS BAJAS DE .. | 2 0.02 98.48 BOUQUIE. COLCHICINE-RELATED TOXICITY .. | 1 0.01 98.49 BUCH T,HOLM J,MUNCK L. MULTIPLE EMBOL.. | 1 0.01 98.50 BUSH LM, DAVIDSON E, DAUGHERTY J.. BO.. | 1 0.01 98.51 BYUN M. CLINICAL OUTCOMES OF TIGECYCL.. | 1 0.01 98.52 BYUN M. CLINICAL OUTCOMES OF TIGECYCL.. | 1 0.01 98.53 BYUN M.. CLINICAL OUTCOMES OF TIGECYC.. | 1 0.01 98.54 BYUN, M.. CLINICAL OUTCOMES OF TIGECY.. | 1 0.01 98.55 BYUN, M.. CLINICAL OUTCOMES OF TIGECY.. | 1 0.01 98.56 CHHABRA L, SPODICK DH. BRUGADA PATTER.. | 1 0.01 98.57 CHIANG CH, CHU CT, WILEY CA. A 67 YEA.. | 1 0.01 98.58 CHOGLE, ARUN R... ROLE OF ANTI-TUMOR .. | 1 0.01 98.59 CIRON J, HAUTECOEUR P, NEAU JP. NATAL.. | 3 0.03 98.62 COLE J,STELLPFLUG S,ENGEBRETSEN K. AS.. | 2 0.02 98.64 COLE JB, ELLSWORTH H, ENGEBRETSEN KM,.. | 1 0.01 98.65 COSGROVE DP; REYES DK; PAWLIK TM; FEN.. | 1 0.01 98.66 DANG, C. DOSE-DENSE DOXORUBICIN AND C.. | 1 0.01 98.67 DAS M, PADDA S, FRYMOYER A, ZHOU L, R.. | 1 0.01 98.68 DENG T, ZHANG L, LIU XJ, XU JM, BAI Y.. | 1 0.01 98.69 DERMATOLOGY ONLINE JOURNAL: GENERALIZ.. | 1 0.01 98.70 DESAI, N.C.. ERYTHEMA MULTIFORME MINO.. | 1 0.01 98.71 DIGBY GC, PEREZ RIERA AR, BARBOSA BAR.. | 1 0.01 98.72 DILL P, DATTA A, WEBER P, SCHNEIDER J.. | 1 0.01 98.73 DINA I. DRUG - INDUCED HEPATITIS SECO.. | 1 0.01 98.74 DONALDSON M,NORBECK A. ADVERSE EVENTS.. | 1 0.01 98.75 DR. LESLIE ABRAMSON, MD. NOVEL METHOD.. | 1 0.01 98.76 EGRON, A.. PREVENTABLE AND POTENTIALL.. | 1 0.01 98.77 ENOMOTO TETSURO ET AL. CLOZAPINE OPTI.. | 1 0.01 98.78 FOSSA A, FISVIK IH, KOLSTAD A, LAURIT.. | 1 0.01 98.79 FOSSA A,FISVIK I,KOLSTAD A,LAURITZSEN.. | 1 0.01 98.80 FUKUDA Y, MOMOI N, MITSUTOMO M, AOYAN.. | 1 0.01 98.81 GAETANI, LORENZO, MENDUNO, PAOLA S.,C.. | 1 0.01 98.82 GAKU MINASE, ET AL.. CASE REPORT OF L.. | 1 0.01 98.83 GRENHA, J.. SEROTONIN SYNDROME AFTER .. | 1 0.01 98.84 GRIMALDI D, DOLOY A, FICHET J, BOURGE.. | 1 0.01 98.85 HABERLAND, A. ARE AGONISTIC AUTOANTIB.. | 1 0.01 98.86 HADA Y, KAMEDA W, TADA K, UMINO K, KA.. | 1 0.01 98.87 HAGIWARA J, HIRAGATA YUKO, MATSUI AKI.. | 1 0.01 98.88 HARUKA HISHIKI, ET. AL.. A CASE OF A .. | 1 0.01 98.89 HERZIG DW, STEMER AB, BELL RS, LIU A-.. | 1 0.01 98.90 HIDEAKI HANAKI. FROM ^CASE QUESTIONS^.. | 1 0.01 98.91 HIROSHI N, KAZUSHIGE F, NAKAYAMA Y, T.. | 1 0.01 98.92 HODEL J, OUTTERYCK O, VERCLYTTE S, DE.. | 1 0.01 98.93 HODEL J, OUTTERYCK O, VERCLYTTE S, DE.. | 1 0.01 98.94 HODEL J, OUTTERYCK O, VERCLYTTE S, DE.. | 2 0.02 98.96 HOLT EW, DAVERN TJ. PRIOR BARIATRIC S.. | 1 0.01 98.97 HOWELL C, LARSON J. TREATMENT OF BIPO.. | 1 0.01 98.98 HUANG SS, XENOCOSTAS A, MOIST LM, CRO.. | 1 0.01 98.99 I. SHAJRAWI. SARCOID -RELATED UVEITIS.. | 1 0.01 99.00 IKEDA M. REACTIVATION OF HEPATITIS B .. | 1 0.01 99.01 ITANO S, ARIMATSU HIDETOSHI, TAJIRI N.. | 1 0.01 99.02 IVAN FENOGLIO. DRUG-INDUCED HYPONATRE.. | 1 0.01 99.03 J.A. HUNTER. ACUTE PSYCHOSIS IN THREE.. | 1 0.01 99.04 JIANU C. 2012 JAN 01;36(7):644-649. | 1 0.01 99.05 KAMEI K, OKADA M, MIYAZONO A AND SATO.. | 1 0.01 99.06 KARMACHARYA, P.. RECURRENT CASE OF IB.. | 1 0.01 99.07 KATSUTA M. A CASES OF KAPOSI^S SARCOM.. | 1 0.01 99.08 KAWANO H, TANAKA H, YAMASHITA T, HIRA.. | 1 0.01 99.09 KAZUHISA KUSUKI, ET.AL.,. THE ANALYSI.. | 1 0.01 99.10 KC S. ACUTE LIVER FAILURE CAUSED BY H.. | 1 0.01 99.11 KEMMOCHI T, SUZUKI Y, YONEDA M, ITO Y.. | 1 0.01 99.12 KIM S, KIM T, LEE K. NICOLAU SYNDROME.. | 1 0.01 99.13 KLEINSCHNITZ C, NIEMCZYK G, REHBERG-W.. | 2 0.02 99.15 KNUDSON, M.. COMMON OVER THE COUNTER .. | 1 0.01 99.16 KOICHI YONEMOTO. OUTCOME WITH ETANERC.. | 1 0.01 99.17 KOLB-M?URER, ANNETTE ; GOEBELER, MATT.. | 1 0.01 99.18 KOSHELEV M.. FIXED DRUG ERUPTION RELA.. | 1 0.01 99.19 KOYAMA H, KOYAMA HIROSHI, YAMAMOTO YU.. | 1 0.01 99.20 KOZASA Y, ET AL. A CASE OF STRESS CAR.. | 1 0.01 99.21 KREMER, J.. TOFACITINIB IN COMBINATIO.. | 1 0.01 99.22 KUBOTA M, NAGAOKA K, NAGAI A, KASHII .. | 1 0.01 99.23 L CASTELLO-SOCCIO. SUCCESSFUL TREATM.. | 1 0.01 99.24 LAKSHMI, G.S.. METRONIDAZOLE ENCEPHAL.. | 1 0.01 99.25 LALONDE L. EFFICACY/SAFETY OF RANIBIZ.. | 1 0.01 99.26 LAMONICA D, GRAF D, ATTWOOD K., MUNTE.. | 1 0.01 99.27 LANDRY JC, FENG Y, PRABHU RS, COHEN S.. | 1 0.01 99.28 LASICA M, ZANTOMIO D. SEVERE INTRAVEN.. | 1 0.01 99.29 LAW JY, KIM DW, STURGIS A, NAINA HV. .. | 1 0.01 99.30 LEHLOENYA R, SHEBE K, HLELA C, DLAMIN.. | 1 0.01 99.31 LEMAS M. HIGH DOSE CYCLOPHOSPHAMIDE (.. | 1 0.01 99.32 LEWANDOWSKA M, GNIOT M, LEWANDOWSKI K.. | 1 0.01 99.33 LI J, FERNANDO SL. SUCCESSFUL RAPID D.. | 1 0.01 99.34 LIN L, HORIGOME H, NISHIGAMI N, OHNO .. | 1 0.01 99.35 LING ET AL. RECURRENT LOWER GASTROINT.. | 1 0.01 99.36 LODISE, M. ACUTE IBUPROFEN INTOXICATI.. | 1 0.01 99.37 LOPEZ, C. DARBEPOETIN VERSUS EPOETIN .. | 1 0.01 99.38 LUNG, D.. GLYBURIDE OVERDOSE FROM ING.. | 1 0.01 99.39 MATSUDA T ET AL. P2-05-02 A CASE OF S.. | 1 0.01 99.40 MATSUNO OT, MATSUI T, KAWAGUCHI Y, FU.. | 1 0.01 99.41 MATSUOKA S, MATSUOKA K, TOYAMA S, OMA.. | 1 0.01 99.42 MATSUURA M, NAKAMURA A, YAMAMOT T. PA.. | 1 0.01 99.43 MAUNG K, O^SHAUGHNESSY J, AND SLEDGE .. | 1 0.01 99.44 MERKELY B,TOTH-ZSAMBOKI E,BECKER D,BE.. | 1 0.01 99.45 MIYAGI T, ITONAGA H, AOSAI F, TAGUCHI.. | 1 0.01 99.46 MURDOCK DK, ET AL. THE EFFECT OF RANO.. | 2 0.02 99.48 MURDOCK, DK, ET AL. THE EFFECT OF RAN.. | 1 0.01 99.49 NA A, HALL N, KAVAR B, KING J. CENTRA.. | 1 0.01 99.50 NATSUKI K, TAMURA M, WATANABE S. ONSE.. | 1 0.01 99.51 NISCOLA P. ATYPICAL MYELODYSPLASTIC/M.. | 1 0.01 99.52 NISHIDA.H, FUKUHARA H, YAMAGISHI A, S.. | 1 0.01 99.53 NISHIYAMAA A, KATAKAMI N, YOSHIOKA H,.. | 1 0.01 99.54 NWAEJIKE N. STATINS CAN INTERACT WITH.. | 1 0.01 99.55 O^MAHONY C. RHABDOMYOLYSIS WITH ATORV.. | 1 0.01 99.56 PALUNGWACHIRA P, PALUNGWACHIRA P, OGA.. | 1 0.01 99.57 PAUL AMES. CONSECUTIVE PSEUDOGOUT ATT.. | 1 0.01 99.58 PAULEY KA, SANDRITTER T, LOWRY J, ALG.. | 1 0.01 99.59 PFEFFER G, PFEFFER G, COTE H, MONTANE.. | 1 0.01 99.60 PFEFFER, G.. OPHTHALMOPLEGIA AND PTOS.. | 1 0.01 99.61 PIA DOGBEY, MARJORIE GOLDEN AND NHU N.. | 1 0.01 99.62 PIRES MC, FERREIRA M, SILVESTRE R, VI.. | 1 0.01 99.63 RODRIGUEZ, A. DARBEPOETIN VS EPOETIN .. | 1 0.01 99.64 RUBIN D, CHAPMAN C, BOCHENEK A, STEIN.. | 1 0.01 99.65 RYUHEI FUJIMOTO ET AL.. A CASE OF GAS.. | 1 0.01 99.66 SAKAMOTO A, MATSUMOTO N, ARIMURA Y, Y.. | 1 0.01 99.67 SANO Y. CONGRESS REPORT OF THE 2015 .. | 1 0.01 99.68 SATTI H., MCLAUGHLIN M.M., SEUNG K.J... | 1 0.01 99.69 SAVVAS SAVVATIANOS ET AL. COW^S MILK .. | 1 0.01 99.70 SAVVATIANOS, S.. COW^S MILK ALLERGY A.. | 1 0.01 99.71 SHIBATA M, MIYAZAKI K, TOJIMA H, HUKU.. | 1 0.01 99.72 SHIBATA M,MIYAZAKI K,TOJIMA H,HUKUZUM.. | 1 0.01 99.73 SILVA G, MENDES A, MACEDO M, PINTO C.. | 2 0.02 99.75 SIMETKA O, MICHALEC I, CRKVENJAS ZN, .. | 1 0.01 99.76 SIPOS N.. THE SEROUS-TYPE OVARIAN SER.. | 1 0.01 99.77 SNOWDON J, HALLIDAY G. A STUDY OF THE.. | 1 0.01 99.78 SOSA, E. VAQUERO. GASTROINTESTINAL BL.. | 1 0.01 99.79 SPADARO M, CALDANO M, MARNETTO F, LUG.. | 1 0.01 99.80 TADA K, YASUNO T, ITO K, ABE Y, MIYAK.. | 1 0.01 99.81 TERUYA, T.. A CASE OF HOMO TYPE FOR U.. | 1 0.01 99.82 THE EFFECT OF CINACALCET ON BONE REMO.. | 1 0.01 99.83 THORNTON SL, NEGUS E, CARSTAIRS SD. P.. | 1 0.01 99.84 TOYAMA H,KUMAGAI K. RELATIONSHIP BETW.. | 1 0.01 99.85 VAN OBBERGHEN E, COHEN M, ROCHER F, L.. | 1 0.01 99.86 VIVES M, ROMANO J, STOLL E, LAFUENTE .. | 1 0.01 99.87 WALKER, T. POTENTIAL LINK BETWEEN HMG.. | 1 0.01 99.88 WALKER, T.. POTENTIAL LINK BETWEEN HM.. | 1 0.01 99.89 WIESNER J. ASSESSMENT REPORT ON HEDER.. | 2 0.02 99.91 YAMAMOTO K, TAKEDA Y, KINOSHITA H, AK.. | 1 0.01 99.92 YLIKOTILA P, KETOLA RA, TIMONEN S, MA.. | 2 0.02 99.94 YOKOYAMA A, KUDO M, KAGOO T, OHASHI K.. | 1 0.01 99.95 YOSHIDA R, TAKAKI K, KUISE T, NOBUOKA.. | 1 0.01 99.96 YOSHIDA Y, YOSHIDA Y, OGURA K, HIRATS.. | 1 0.01 99.97 YOSUKE FUKIISHI. A CASE OF COMPLICATE.. | 1 0.01 99.98 YU H, JOHNSON M, URMAN A, RADEMAKER A.. | 1 0.01 99.99 ZHENG D. CLINICAL EVALUATION OF FUNG.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017